Cancer: Guided Therapeutics, Konica Minolta in esophageal cancer pact

February 6, 2013 by MassDevice staff

Guided Therapeutics will take development of its esophageal cancer detection device in-house under the terms of new deal with Konica Minolta.

Guided Therapeutics

Guided Therapeutics (OTC:GTHP) and its largest customer, Konica Minolta (TYO:4902), agreed to alter a development deal for an esophageal cancer detection device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp